Dog /
FDA CVM · 2025 release 1,555 reports on file

Corgi - Welsh Pembroke - FDA Adverse Event Profile

Adverse-event records for Corgi - Welsh Pembroke (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 126 94.5 63 31.5 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Corgi - Welsh Pembroke drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

Among dog breeds, Corgi - Welsh Pembroke is #87 by FDA report volume; 4.2% of its 1,555 reports (65) were death-coded.

#87
most-reported dog breed
4.2%
death-coded report share
338
Vomiting - top reaction
5.2 yr
average age at report

Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.

Total Reports

1,555

FDA CVM filings

Deaths Reported

65

of 1,555 reports

Death Rate

4.2%

death-coded share

Avg Age at Report

5.2 yr

12.9 kg avg weight

Death-Coded Outcome Share

Corgi - Welsh Pembroke death-coded reports 4.2%
Cross-breed median

4.2% of 1,555 corgi - welsh pembroke reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 12.9 kg (28.4 lbs)

Top Reported Reactions

Vomiting 338
Emesis 166
Lethargy (see also Central nervous system depression in 'Neurological') 160
Diarrhoea 158
Lack of efficacy (endoparasite) - hookworm 106
Lack of efficacy (ectoparasite) - flea 81
Digestive tract disorder NOS 70
Lack of efficacy - NOS 63
Emesis (multiple) 60
Seizure NOS 50
Behavioural disorder NOS 49
Other abnormal test result NOS 42
Lack of efficacy (endoparasite) - heartworm 41
Anorexia 39
Lack of efficacy (endoparasite) - roundworm NOS 39

Most Referenced Drugs

Milbemycin Oxime + Spinosad 355
Ivermectin + Pyrantel As Pamoate Salt 162
Pyrantel Pamoate;Sarolaner 122
Fluralaner Chew Tablets 117
Afoxolaner 110
Fluralaner 13.64% 12-Week Chew 82
Imidacloprid + Moxidectin 59
Spinosad 57
Trilostane 57
Milbemycin Oxime + Praziquantel 55
Carprofen 37
Lotilaner 36
Moxidectin 32
Ivermectin + Pyrantel 29
Oclacitinib Maleate 27

Outcome Breakdown

Recovered/Normal
627 (40.3%)
Outcome Unknown
449 (28.8%)
Ongoing
368 (23.6%)
Recovered with Sequela
47 (3.0%)
Died
35 (2.2%)
Euthanized
31 (2.0%)

Gender Distribution

Male 765 (49.2%)
Female 752 (48.4%)
Unknown 32 (2.1%)
Mixed 6 (0.4%)

Reports by Year

Year Reports Trend
2010 1
2011 14
2012 77
2013 141
2014 103
2015 108
2016 142
2017 128
2018 126
2019 106
2020 110
2021 98
2022 102
2023 108
2024 108
2025 83

Corgi - Welsh Pembroke Pet Health Insights

Corgi - Welsh Pembroke accounts for 1,555 FDA adverse event reports, ranking #87 by volume among dog breeds, with 65 reports (4.2%) coded as a death outcome. Mean age at report: 5.2 years, average weight 12.9 kg (28.4 lbs).

Top reported signs: Vomiting (338), Emesis (166), Lethargy (see also Central nervous system depression in 'Neurological') (160). Most-referenced drug: Milbemycin Oxime + Spinosad (355 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (162) and Pyrantel Pamoate;Sarolaner (122).

Outcome coding on 1,557 status-recorded reports is dominated by Recovered/Normal (40.3%). Annual submissions ranged 2,010-2,025 across 16 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Corgi - Welsh Pembroke?
There are 1,555 adverse event reports involving Corgi - Welsh Pembroke in the FDA database, with 65 reports involving death (4.2% death rate). Corgi - Welsh Pembroke ranks #87 by report volume.
What are the most common adverse reactions reported for Corgi - Welsh Pembroke?
The most commonly reported adverse reactions for Corgi - Welsh Pembroke are Vomiting (338 reports), Emesis (166 reports), Lethargy (see also Central nervous system depression in 'Neurological') (160 reports), Diarrhoea (158 reports), Lack of efficacy (endoparasite) - hookworm (106 reports).
What drugs are most frequently associated with Corgi - Welsh Pembroke adverse events?
The drugs most frequently referenced in Corgi - Welsh Pembroke adverse event reports are Milbemycin Oxime + Spinosad (355 reports), Ivermectin + Pyrantel As Pamoate Salt (162 reports), Pyrantel Pamoate;Sarolaner (122 reports), Fluralaner Chew Tablets (117 reports), Afoxolaner (110 reports).
What is the average age of Corgi - Welsh Pembroke in adverse event reports?
The average age of Corgi - Welsh Pembroke at the time of adverse event reports is 5.2 years, with an average weight of 12.9 kg (28.4 lbs).
Does a high number of adverse event reports mean Corgi - Welsh Pembroke is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Corgi - Welsh Pembroke safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.